跳至主要内容
临床试验/CTRI/2021/07/034646
CTRI/2021/07/034646已完成未知

EFFICACY OF ASPIRIN 75 mg VS 150 mg FOR PREVENTION OF PREECLAMPSIA IN MULTIMARKER SCREEN POSITIVE HIGH RISK WOMEN.

Balram pandit0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ââ?¬Â¢Previous history of preeclampsia
  • ââ?¬Â¢nulliparity
  • ââ?¬Â¢short( <12months) or long (72months) inter pregnancy interval
  • ââ?¬Â¢h/o ART
  • ââ?¬Â¢family h/o chronic hypertension.
  • ââ?¬Â¢Obesity (BMI >29.9)
  • ââ?¬Â¢comorbidities like SLE, chronic hypertension, APS, kidney disease, DM

排除标准

  • 1.allergic to aspirin and aspirin is contra indicated for medical reasons
  • 2.refusal for consent
  • 3.significant fetal malformations or presence of aneuploidy
  • 4.low platelet count
  • 5. patient on anticoagulation
  • 6. patient already on aspirin

研究者

发起方
Balram pandit

相似试验